Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Doc Bones who wrote (8330)	5/12/2003 9:52:40 AM
From: Biomaven	Respond to of 52153

Interesting that GZBX is now trading at a 5% premium to the "take-under" price. (Last week it was trading at a small discount). Perhaps an indication that GENZ will have to sweeten its offer some? Legally I suspect that the tracking stock holders don't have too strong a case - they got what they signed up for. But it may be easier for GENZ to just pay up modestly than contest a suit with its attendant unfavorable publicity. I recall a situation a few years back where GENZ engaged in what amounted to insider trading in one of these stocks (maybe GZTC?) - it sold a bunch of shares ahead of some bad news. Peter